Invesco Ltd. Dr Reddys Laboratories LTD Transaction History

Invesco Ltd.

$600 Billion
Q3 2025

A detailed history of Invesco Ltd. transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Invesco Ltd. holds 313,746 shares of RDY stock, worth $4.37 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

313,746

Previous 253,342 23.84%

Holding current value

$4.37 Million

Previous $3.81 Million 15.21%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$13.33 - $15.08 $805,185 - $910,892	60,404 Added 23.84%	313,746 $4.39 Million
Q2 2025 Aug 13, 2025	BUY	$12.36 - $16.17 $221,330 - $289,556	17,907 Added 7.61%	253,342 $3.81 Million
Q1 2025 May 12, 2025	BUY	$12.53 - $15.81 $401,348 - $506,410	32,031 Added 15.75%	235,435 $3.11 Million
Q4 2024 Feb 13, 2025	BUY	$13.99 - $79.75 $2.33 Million - $13.3 Million	166,526 Added 451.56%	203,404 $3.21 Million
Q3 2024 Nov 12, 2024	BUY	$75.41 - $84.21 $141,921 - $158,483	1,882 Added 5.38%	36,878 $2.93 Million

Q2 2024 Aug 13, 2024	BUY	$68.26 - $76.19 $236,179 - $263,617	3,460 Added 10.97%	34,996 $2.67 Million
Q1 2024 May 14, 2024	SELL	$67.36 - $77.59 $1.59 Million - $1.83 Million	-23,640 Reduced 42.84%	31,536 $2.31 Million
Q4 2023 Feb 12, 2024	SELL	$64.27 - $69.9 $23,394 - $25,443	-364 Reduced 0.66%	55,176 $3.84 Million
Q3 2023 Nov 13, 2023	SELL	$61.9 - $72.77 $700,274 - $823,247	-11,313 Reduced 16.92%	55,540 $3.71 Million
Q2 2023 Aug 11, 2023	SELL	$53.34 - $63.11 $32,964 - $39,001	-618 Reduced 0.92%	66,853 $4.22 Million
Q1 2023 May 12, 2023	SELL	$51.63 - $56.93 $965,222 - $1.06 Million	-18,695 Reduced 21.7%	67,471 $3.84 Million
Q4 2022 Feb 13, 2023	BUY	$51.15 - $57.45 $694,258 - $779,768	13,573 Added 18.7%	86,166 $4.46 Million
Q3 2022 Nov 14, 2022	BUY	$49.9 - $57.32 $3.44 Million - $3.95 Million	68,928 Added 1880.71%	72,593 $3.8 Million
Q2 2022 Aug 15, 2022	SELL	$49.62 - $58.13 $3.82 Million - $4.48 Million	-77,069 Reduced 95.46%	3,665 $202,000
Q1 2022 May 16, 2022	BUY	$48.27 - $65.25 $3.25 Million - $4.39 Million	67,322 Added 501.95%	80,734 $4.5 Million
Q4 2021 Feb 14, 2022	BUY	$59.5 - $67.25 $69,020 - $78,010	1,160 Added 9.47%	13,412 $877,000
Q3 2021 Nov 15, 2021	SELL	$60.19 - $75.29 $507,100 - $634,318	-8,425 Reduced 40.75%	12,252 $798,000
Q2 2021 Aug 17, 2021	BUY	$62.12 - $74.2 $1.28 Million - $1.53 Million	20,677 New	20,677 $1.52 Million
Q1 2021 May 17, 2021	SELL	$57.98 - $73.08 $1.04 Million - $1.31 Million	-17,953 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$62.61 - $71.29 $116,391 - $132,528	-1,859 Reduced 9.38%	17,953 $1.28 Million
Q3 2020 Nov 16, 2020	BUY	$51.39 - $72.41 $1.02 Million - $1.43 Million	19,812 New	19,812 $1.38 Million
Q2 2019 Aug 14, 2019	SELL	$36.05 - $42.76 $286,020 - $339,257	-7,934 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$35.77 - $40.57 $24,681 - $27,993	-690 Reduced 8.0%	7,934 $321,000
Q4 2018 Feb 14, 2019	BUY	$31.89 - $38.44 $275,019 - $331,506	8,624 New	8,624 $326,000

Others Institutions Holding RDY

# of Institutions

250

Shares Held

94.4M

Call Options Held

Put Options Held

View Full List

About DR REDDYS LABORATORIES LTD

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $2.31B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

More about RDY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account